Dr. Reddy

Drug maker Dr. Reddys Laboratories Ltd said on Wednesday it launched lamotrigine extended-release tablets in the US market following approval by the Food and Drug Administration on 25 June.
Lamotrigine is a generic version of GlaxoSmithKline Plc.s lamictal XR used in the treatment of epilepsy.
According to US-based healthcare information service provider IMS Health, the lamictal XR brand and its generic had combined US sales of around $300.5 million for the 12 months ended April.
Dr. Reddys lamotrigine tablets will be available in 25mg, 50mg, 100mg, 200mg, and 300mg dosages.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Tags:

Related International


whatsapp--v1